Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: Bob Barels who wrote (771)	3/29/1998 7:19:00 AM
From: george m. miller	Respond to of 887

Good morning Bob....I wish you would reconsider your position on talking with the DEPO people at your presentation in the Netherlands this week. You may be able to find out exactly why and how they failed so badly in front of the FDA. As you know the are scheduled to meet with the FDA again with expanded data. Do they feel the new data will overcome the previous FDA objections? I,am sure it would ease the minds of many current and past holders of this stock if they could hear from someone who had actually met (confront?) them face to face. Again, will you meet with them and let us know how they see their present situation. Thanks for any assistance, George

To: Bob Barels who wrote (771)	3/29/1998 9:58:00 AM
From: BD	Respond to of 887

Your attitude in last two posts on this thread is one of critisism and condemnation. For what its worth anyone who intentionally does this I feel sorry for. I am long depo at this level based on the delivery technology. Irregardless of DC outcome, the technology has value and DM could be a very big winner for this company. As far as Dr. D's unfortunate experience, my investment style is sculpted from a similar experience in a business investment loss encountered over 10 years ago. It was on the same magnitude and my ignorance of what to belive and not to belive was responsible.

To: Bob Barels who wrote (771)	3/30/1998 6:34:00 PM
From: seminole	Read Replies (1) \| Respond to of 887

<<Off Topic>> Lets see. DEPO goes from $15/sh to $3/sh and is panned by BOB while BOB promotes ETHCY that over a similar period of time goes from $6/sh to $1/sh. Bob thinks a loss of five dollars a share is much better than a loss of twelve dollars a share. Gee, will Bob be as happy when he finds out he actually had a larger percentage loss? ETHCY VS DEPO <<It is a controlled drug release company ( My Ph.D and all my publications are in this field) and I am very familiar with their work.> For now I will except your position on which company has a better drug delivery system. Damn, looks like its off to the BioMED library. <<Their recent drop came as a result of the departure of Dr. Guy, CEO.>> If my company's stock was about to go from $6/sh to $1/sh, I get out too. Our resent drop at DEPO resulted in a couple of departures. Giving references for opinions is a good research practice richard